Skip to main content
Premium Trial:

Request an Annual Quote

Second Suit Claims Affy Officials Gained $115.3M from Sale of Backdated Stock Option Grants

NEW YORK (GenomeWeb News) – A second shareholder has filed suit against Affymetrix officials for improperly backdating stock option grants, GenomeWeb News has learned.
The suit, filed Sept. 13 in the United States District Court for the Northern District of California, follows a similar but separate suit filed in the same court on Aug. 30, and accuses 12 Affy officials of diverting “hundreds of millions of dollars of corporate assets to themselves via the manipulation of grant dates associated with hundreds of thousands of stock options granted to Affymetrix insiders.”
The suit, filed derivatively by Affymetrix shareholder Samuel Powers, alleges that the backdated option grants enabled the defendants to sell more than $115.3 million worth of Affymetrix stock “at artificially inflated prices” between 1997 and 2006.
An attorney associated with the first shareholder suit confirmed today that the two complaints are separate.
Affymetrix disclosed in early August that it had uncovered “certain documentation lapses” in its stock-option granting practices and would need to restate its financial results dating back to 1997.
The company said that it had completed its financial restatement on Aug. 30.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.